Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Taiko Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,904	16,614	15,082	17,193	35,911	69,826
Market Cap Growth	-27.51%	10.16%	-12.28%	-52.12%	-48.57%	4.58%
Enterprise Value	10,858	14,070	13,285	17,038	34,790	61,349
Last Close Price	277.00	331.00	303.00	394.00	824.00	1601.01
PE Ratio	19.36	18.50	-	-	-	16.71
Forward PE	48.17	-	-	-	-	13.48
PS Ratio	2.29	2.64	2.46	3.41	3.18	3.11
PB Ratio	1.74	2.09	2.24	2.14	2.80	3.07
P/TBV Ratio	1.75	2.09	2.24	2.20	2.87	3.11
P/FCF Ratio	-	81.04	-	-	-	-
P/OCF Ratio	-	45.90	-	-	-	-
PEG Ratio	-	4.03	4.03	4.03	4.03	4.03
EV/Sales Ratio	1.79	2.24	2.17	3.38	3.08	2.73
EV/EBITDA Ratio	15.14	15.88	-	-	-	8.89
EV/EBIT Ratio	23.60	22.33	-	-	-	9.78
EV/FCF Ratio	-	68.64	-	-	-	-
Debt / Equity Ratio	0.20	0.26	0.48	0.47	0.37	0.00
Debt / EBITDA Ratio	2.27	2.29	-	-	-	0.01
Debt / FCF Ratio	-	9.89	-	-	-	-
Asset Turnover	0.48	0.48	0.43	0.27	0.42	-
Inventory Turnover	1.51	1.72	2.13	1.54	1.78	-
Quick Ratio	2.60	2.44	2.45	1.90	2.35	1.72
Current Ratio	3.42	3.07	2.99	2.71	3.19	2.65
Return on Equity (ROE)	9.32%	12.22%	-48.86%	-46.96%	-53.92%	-
Return on Assets (ROA)	2.31%	3.01%	-4.45%	-10.24%	-11.39%	-
Return on Capital (ROIC)	2.91%	3.94%	-5.76%	-13.07%	-15.29%	-
Return on Capital Employed (ROCE)	4.70%	6.30%	-	-	-	25.80%
Earnings Yield	5.16%	5.41%	-23.94%	-28.47%	-26.72%	5.98%
FCF Yield	-	1.23%	-2.68%	-11.97%	-8.55%	-6.99%
Dividend Yield	-	-	-	-	-	1.48%
Payout Ratio	-	0.11%	-	-	-	26.97%
Buyback Yield / Dilution	-2.45%	-5.96%	-8.62%	-0.21%	-0.35%	-1.32%
Total Shareholder Return	-	-5.96%	-8.62%	-0.21%	-0.35%	0.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.